| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.095 | 0.6 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |